Lv5
930 积分 2023-08-09 加入
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
1年前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1年前
已完结
Sex differences in kidney metabolism may reflect sex-dependent outcomes in human diabetic kidney disease
1年前
已完结
Mercury-Associated Nephrotic Syndrome: A Case Report and Systematic Review of the Literature
1年前
已完结
Mercury Intoxication as a Rare Cause of Membranous Nephropathy in a Child
2年前
已完结
皖公网安备34019202002308
